Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-26 @ 3:18 PM
NCT ID: NCT07488858
Eligibility Criteria: Inclusion Criteria: * Both Male or female patients. * Patients aged 18 to 65 years undergoing thyroidectomy for benign or malignant thyroid disease. * Patients with multinodular goiter, Grave's disease, thyroid carcinoma indicated for surgery based on their workup. * Candidates scheduled for unilateral lobectomy, subtotal thyroidectomy, or total thyroidectomy. * Patients with preoperative normal vocal cord mobility confirmed by laryngoscopy. Hemodynamically stable patients without significant comorbidities affecting surgery or anesthesia based on ASA classification (Class I-III). • Patients who provide informed consent to participate in the study. Exclusion Criteria: • Prior history of prior thyroid surgery. * Patients with evidence of lateral lymph node metastasis or local invasion on preoperative imaging (ultrasonography or computed tomography). * Patients with pre-existing hypocalcemia or parathyroid disorders. * Patients with severe medical comorbidities, including uncontrolled diabetes (HbA1c \> 8%), chronic kidney disease (eGFR \< 30 mL/min/1.73m²), liver cirrhosis (Child-Pugh class B or C), or coagulopathy (INR \> 1.5 or platelet count \< 50,000/μL), will be excluded from the study. * Pregnant or lactating women. * Patients with invasive thyroid carcinoma, anaplastic thyroid carcinoma, or thyroid lymphoma requiring extensive radical surgery.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT07488858
Study Brief:
Protocol Section: NCT07488858